N-(1,3,4,6,7,12b-hexahydro-2H-benzo[b]furo[2,3-a]quinolizin -2-yl)-N- methyl-2-hydroxyethane-sulfonamide: a potent and selective alpha 2-adrenoceptor antagonist.
D000818:Animals; D001667:Binding, Competitive; D002417:Cattle; D002540:Cerebral Cortex / Q000378:metabolism; D055598:Chemical Phenomena; D002621:Chemistry; D003000:Clonidine / Q000494:pharmacology; D008297:Male; D011224:Prazosin / Q000378:metabolism; D011680:Pupil / Q000187:drug effects; D011807:Quinolizines / Q000138:chemical synthesis / Q000378:metabolism / Q000494:pharmacology*; D051381:Rats; D011942:Receptors, Adrenergic, alpha / Q000378:metabolism*; D013237:Stereoisomerism; D013329:Structure-Activity Relationship; D015016:Yohimbine / Q000378:metabolism
D011807:Quinolizines; D011942:Receptors, Adrenergic, alpha; D015016:Yohimbine; C047289:N-(1,3,4,6,7,12b-hexahydro-2H-benzo(b)furo(2,3-a)quinolizin-2-yl)-N-methyl-2-hydroxyethanesulfonamide; D003000:Clonidine; D011224:Prazosin